Anixa Biosciences is trading at $2.84, up 6.97% after hours, with the rise unexplained pending further news.
- The latest company announcement, on October 13, concerned a planned conference keynote and does not clearly explain the move.
- The broader market was sharply lower, so market sentiment does not clearly account for the stockβs move in the opposite direction; available reporting also noted no clear company-specific catalyst.